Skip to content
DataLookout
Menu

NCT07830056

Modafinil to Optimize the Performance of Cold-Stressed Sleep-Deprived Personnel

StatusCompleted
PhasePhase 4
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Trial completed
    • Study completion date changed from estimate of Dec 2026 to Sep 24, 2026
    • Site details revised
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Height (in)
Timeframe: Familiarization 1 (Day -2)
Body Weight (kg)
Timeframe: Familiarization 1 (Day -2)
Body Composition: DXA Fat Mass (lbs)
Timeframe: Familiarization 1 (Day -2)
Body Composition: DXA Lean Mass (lbs)
Timeframe: Familiarization 1 (Day -2)
Body Composition: DXA Bone Mineral Content (lbs)
Timeframe: Familiarization 1 (Day -2)
Sleep & Physical Activity
Timeframe: Familiarization 1 to Study Completion (11 Days)
Cold Exposure: Core Temperature
Timeframe: Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cold Exposure: Skin Temperature
Timeframe: Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Dexterity: Finger Tapping Task (FTT)
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Scanning Visual Vigilance
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Psychomotor Vigilance Test (PVT)
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Matching to Sample
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Grammatical Reasoning
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Go/No-Go Task
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: N-Back Task
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Cognitive Assessment: Task-Switching Task
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)
Physical Performance: Grip Strength
Timeframe: Familiarization 1 (Day -2), Familiarization 2 (Day -1), Baseline Assessment (Day 0), Cold Exposure (Days 2 & 3), Cold Exposure (Days 6 & 7)

Secondary (11)

Cognitive Assessment: Balloon Analogue Risk Task (BART)
Assessment of Blinding
Dietary Intake
Cold Exposure: Environmental Symptoms Questionnaire (ESQ)
Mood Assessment: Profile of Mood States Questionnaire (POMS 2-A)
Show 6 moreShow less
Mood Assessment: Buss-Perry Aggression Questionnaire
Mood Assessment: Felt Arousal Scale (FAS)
Mood Assessment: Feeling Scale (FS)
Resilience: Connor-Davidson Resilience Scale (CD-RISC-25)
Background Survey
Adverse Events

Arms and interventions

PlaceboPlacebo comparator

200 mg Microcrystalline Cellulose

ModafinilActive comparator

200 mg Modafinil

Drugs: Modafinil (M), 200 mg Microcrystalline Cellulose

Sites

1 site in 1 country

  • US Army Research Institute of Environmental MedicineNatick, Massachusetts, United States